Blood Test-Guided antidepressant dosing aims to boost safety and speed up relief
NCT ID NCT07478796
First seen Mar 27, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tests whether measuring drug levels in the blood can help doctors give the right dose of common antidepressants (sertraline or escitalopram) to hospitalized children and adults with major depression. About 180 participants will receive personalized dosing based on these measurements. The goal is to improve symptom relief, reduce side effects, and shorten the time to feeling better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Szpital Kliniczny im. Karola Jonschera UMP (Poznan University of Medical Sciences)
RECRUITINGPoznan, Greater Poland Voivodeship, 60-572, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.